Endobronchial Ultrasound and Lymphoproliferative Disorders: A Retrospective Study
|
|
- Solomon Grant
- 5 years ago
- Views:
Transcription
1 Endobronchial Ultrasound and Lymphoproliferative Disorders: A Retrospective Study Seher Iqbal, MD,* Zachary S. DePew, MD,* Paul J. Kurtin, MD, Anne-Marie G. Sykes, MD, Geoffrey B. Johnson, MD, Eric S. Edell, MD, Thomas M. Habermann, MD, and Fabien Maldonado, MD Division of Pulmonary and Critical Care Medicine, Department of Laboratory Medicine and Pathology, Department of Diagnostic Radiology, and Department of Hematology, Mayo Clinic, Rochester, Minnesota Background. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has been shown to have excellent diagnostic performance for mediastinal staging of lung cancer. The utility of EBUS- TBNA for the diagnosis of lymphoproliferative disorders involving the mediastinum or hila, or both, is unclear. Methods. A retrospective analysis was completed of all patients diagnosed with a lymphoproliferative disorder involving the mediastinum or hila, or both, who underwent an EBUS-TBNA within 3 months of the diagnosis. Results. Sixty-five patients with mediastinal or hilar lymph node, or both, involvement of their lymphoproliferative disorder underwent EBUS-TBNA within 3 months of their diagnosis. The initial EBUS-TBNA was nondiagnostic in 34 (52%), 11 were subsequently diagnosed by mediastinoscopy, and the remaining 23 were diagnosed by biopsy of a distant site, with involvement of the mediastinum or hilum assumed from preestablished radiographic criteria. A EBUS-TBNA specimen in 31 patients (48%) was interpreted as consistent with or suspicious for a lymphoproliferative disorder. The overall sensitivity of EBUS-TBNA for establishing a definitive diagnosis was 25 of 65 (38%). The sensitivity was lower for new patients, at 7 of 32 (22%), and better for patients with recurrence, at 18 of 33 (55%). Conclusions. Contrary to previous studies, our findings suggest that EBUS-TBNA does not provide sufficient diagnostic material for accurate lymphoproliferative disorder subtyping in a significant number of patients and performs especially poorly when evaluating new patients. Mediastinoscopy should still be considered as the initial diagnostic procedure of choice when the clinical suspicion for a lymphoproliferative disorder is high, unless the patient is being evaluated for a recurrence of prior disorder. (Ann Thorac Surg 2012;94:1830 4) 2012 by The Society of Thoracic Surgeons Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is increasingly used in the initial evaluation of isolated mediastinal and hilar lymphadenopathy. EBUS-TBNA has been shown to have excellent diagnostic accuracy for the mediastinal staging of non-small cell lung cancer and to be cost-beneficial compared with mediastinoscopy as an initial approach in this context [1 8]. EBUS-TBNA has also been shown to have excellent performance characteristics for the diagnosis of benign etiologies of mediastinal lymphadenopathy, including sarcoidosis [5, 9 11]. The utility of EBUS-TBNA for the diagnosis of lymphoproliferative disorders affecting the mediastinal and hilar lymph nodes is less clear. For the purposes of this report, the term lymphoproliferative disorder (LPD) applies to B-cell chronic lymphocytic leukemia, T-cell prolymphocytic leukemia, Hodgkin lymphoma, and malignant lymphomas with B-cell and T-cell lineage. The sensitivity of EBUS-TBNA for the diagnosis of LPDs has been reported between 57% and 91% [12 14]. As such, it has been suggested that EBUS-TBNA could be Accepted for publication Aug 17, *These authors contributed equally to this manuscript. Address correspondence to Dr Maldonado, Mayo Clinic, Division of Pulmonary and Critical Care Medicine, 200 First St SW, Rochester, MN 55905; maldonado.fabien@mayo.edu. considered as the initial diagnostic approach in patients with isolated mediastinal or hilar lymphadenopathy suspicious for a LPD. However, in addition to being limited by small sample size, 20% to 25% of the patients diagnosed with a LPD by EBUS-TBNA in these studies required subsequent analysis of a surgical biopsy specimen to establish a specific histologic diagnosis. Although a presumptive diagnosis of a LPD can be established in most patients by EBUS-TBNA, the current standard of care for lymphoma treatment is based on diagnosis and classification by World Health Organization criteria [15]. This can only be established when sufficient tissue is available for pathologic evaluation. To clarify the utility of EBUS-TBNA in this setting, we reviewed our institutional experience with use of EBUS-TBNA for the diagnosis of LPDs. The purpose of this study was to evaluate the adequacy of specimens obtained by EBUS-TBNA for the specific diagnosis of a LPD in a cohort of patients ultimately diagnosed with mediastinal or hilar involvement by a LPD. Patients and Methods This study was approved by the Institutional Review Board of the Mayo Clinic College of Medicine (IRB 2012 by The Society of Thoracic Surgeons /$36.00 Published by Elsevier Inc
2 Ann Thorac Surg IQBAL ET AL 2012;94: EBUS-TBNA FOR LYMPHOPROLIFERATIVE DISEASES # ). The Mayo Clinic Lymphoma Database identified all patients diagnosed with a LPD from June 2006 through August This cohort was crossreferenced with our EBUS-TBNA database to determine which of these patients had an EBUS-TBNA procedure with sampling of mediastinal or hilar lymphadenopathy, or both, performed within 3 months of their diagnosis. Of the 3,040 patients who were diagnosed with a LPD during the inclusion timeframe, 129 (4%) had undergone evaluation with EBUS-TBNA within 3 months of the diagnosis for isolated mediastinal or hilar lymphadenopathy, or both. A retrospective analysis of their medical records was completed with extraction of the following data: demographics, history of malignancy, location of all lymph nodes sampled during EBUS-TBNA, and pathologic (histologic/cytologic) results from the EBUS-TBNA and all subsequent procedures. Nodal stations were initially defined according to the 1997 International Staging System until the updated International Association for the Study of Lung Cancer lymph node map was published in 2009, which was used thereafter [16, 17]. Review of the electronic medical records determined that 65 of the 129 patients (50%) had an active diagnosis of a LPD based on mediastinal or hilar lymphoid tissue acquired during EBUS-TBNA or another surgical intervention. For a more conservative analysis, mediastinal or hilar lymph nodes from patients diagnosed on the basis of biopsy specimens from sites other than the chest were assumed to be involved if considered highly suspicious by radiographic criteria (see below). The remaining 64 patients (50%) had a history of LPD, negative EBUS- TBNA, and no subsequent biopsy specimens demonstrating evidence of recurrent disease. These patients remained in remission after continued surveillance for 1 year after EBUS-TBNA. Radiographic Review All relevant imaging studies completed within 6 months of EBUS-TBNA were retrospectively reviewed by 2 radiologists, 1 with expertise in thoracic radiology (A.G.S.) and 1 with expertise in nuclear radiology (G.B.J). The diagnostic quality of all reviewed radiographic studies was adequate based on criteria that included subjective image quality, slice thickness, positron emission tomography-computed tomography (PET-CT) protocol variables, and patient serum glucose level. CT imaging features considered benign included a normal fatty hilum and nodular calcification (unless previously irradiated). CT imaging features considered malignant included a short-axis dimension exceeding 10 mm, focal low density suggestive of necrosis, surrounding fat infiltration suggestive of pericapsular invasion, and hilar lymph nodes with convex margins that deformed the surrounding structures. For PET-CT imaging, a modified London criterion was used where scores of 1, 2, or 3 were considered negative, and scores of 4 or 5 were considered positive for malignancy [18]. PET-CT features considered benign included fluorodeoxyglucose uptake at or below the level of surrounding 1831 vascular structures, a standardized uptake value maximum of less than that of the patient s normal liver and greater than 70 Hounsfield units on the CT component. Fluorodeoxyglucose uptake on PET imaging was required to be focal in nature with a corresponding CT imaging abnormality to be considered positive for malignancy. Owing to the potential for artifactual alterations in fluorodeoxyglucose uptake, clinical discretion was used when (1) EBUS-TBNA was performed within 7 days before PET-CT imaging, (2) chemotherapy was given within 14 days before PET-CT imaging, (3) patients were on continued steroid therapy, or (4) patients had received previous radiation to the area in question. Each lymph node region sampled by EBUS-TBNA was evaluated separately and defined as involved by a LPD if it met the above mentioned criteria by CT or PET-CT imaging. Pathologic Review All EBUS-TBNA tissue samples from cases determined to represent a diagnosis of a LPD by aforementioned criteria were reviewed without knowledge of clinical or radiographic data by an experienced hematopathologist (P.J.K.) to determine if (1) the acquired tissue was sufficient to establish the diagnosis of a specific LPD and (2) if subtyping of the LPD by World Health Organization lymphoma classification criteria was sufficient to independently determine appropriate therapeutic management. Materials reviewed included cytology preparations and tissue sections stained with hematoxylin and eosin. Immunoperoxidase stains, performed by standard methods, were applied in selected cases. Primary antibodies directed against the following antigens were used: cluster of differentiation (CD) 2, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD20, CD23, CD30, CD43, CD45, activin receptor-like kinase-1, paired box protein-5, and T-cell leukemia/lymphoma 1. Because tissue was limited, the antibody panels selected for each case reflected the morphologic differential diagnosis and were not uniformly applied to each case. All lymphomas and leukemias were classified by the World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues criteria [15]. We compared the review pathology results with the initial pathology results reported in the electronic medical records. EBUS-TBNA Procedures All procedures were completed using conscious sedation. Patients were intubated with an uncuffed wire spiral endotracheal tube over a conventional flexible videobronchoscope (Olympus BF-P160/BF-Q180, Olympus America Inc, Center Valley, PA), which was then used for routine airway inspection before EBUS-TBNA. The conventional bronchoscope was then exchanged for the linear-array ultrasonic bronchoscope (Olympus BF- UC160F-0L8). Comprehensive and systematic ultrasound examinations of the mediastinum and hila were performed, followed by TBNA of lymph nodes, at the discretion of the proceduralist, with a 21-gauge needle. All biopsy specimens were obtained with a minimum of
3 1832 IQBAL ET AL Ann Thorac Surg EBUS-TBNA FOR LYMPHOPROLIFERATIVE DISEASES 2012;94: Fig 1. Diagram illustrates the procedure by which diagnosis was made, the number of recurrent cases, and final diagnosis. (BCL B-cell lymphoma; EBUS-TBNA endobronchial ultrasound-guided transbronchial needle aspiration; HL Hodgkin lymphoma; LPD lymphoproliferative disease; MALT mucosa associated lymphoid tissue lymphoma; PTLD posttransplant lymphoproliferative disorder; SLL/CLL small lymphocytic lymphoma/chronic lymphocytic leukemia; TCL T-cell lymphoma.) three needle passes, unless two needle passes resulted in visible core obtained with each pass [19]. Flow cytometry was not used to favor histologic evaluation because subtyping of LPDs is not possible by flow cytometry. Molecular genetic analysis and fluorescence in situ hybridization were performed when appropriate. Results Of the 3,040 patients who were diagnosed with a LPD during the inclusion time frame, 129 (4%) had undergone evaluation with EBUS-TBNA within 3 months of the diagnosis for isolated mediastinal or hilar lymphadenopathy, or both. Of these patients, 65 were considered to have mediastinal or hilar involvement, or both, by the LPD based on histologic lymph node examination (n 42) or a combination of other biopsy specimens and positive radiographic criteria (n 23). A history of a LPD was present in 30 of these patients (46%). All EBUS- TBNA results and final diagnoses are shown in Figure 1. A review of the medical records revealed that the EBUS-TBNA biopsy specimen was nondiagnostic in 34 of the 65 patients (52%), and 11 (32%) underwent mediastinoscopy to establish the diagnosis. Of these 11 patients, 8 (73%) had a new diagnosis of a LPD, and the remaining 3 had a recurrence of a prior LPD. Of the remaining 23 of 34 patients (68%), the diagnosis was determined by analysis of a specimen from a biopsy performed at a distant site, and mediastinal or hilar involvement, or both, was assumed from the previously established radiographic criteria. A new diagnosis of a LPD was established in 15 of 23 patients (65%), with the remaining 8 (45%) representing recurrence of a prior LPD. An endobronchial mucosal biopsy specimen was obtained in 8 patients at the time of the bronchoscopy that established the diagnosis, despite a negative EBUS- TBNA. Other biopsy sites included the pancreas (n 1), jejunum (n 1), liver (n 1), colon (n 1), bone marrow (n 1), and lymph nodes in the cervical (n 4), inguinal (n 3), or axillary (n 2) regions. One patient demonstrated recurrent disease at autopsy. In 31 of 65 patients (48%), an EBUS-TBNA specimen was interpreted as consistent with or suspicious for a LPD. Of these 31 patients, the specimen was sufficient for definitive diagnosis in 25 (81%), and 18 of these 25 (72%) had a history of a LPD and were assumed to have the same subtype as before. The remaining 6 patients (19%) required subsequent mediastinoscopy, 2 for further subtyping of the LPD and management guidance, and 4 to establish a diagnosis of a LPD after detection of atypical or suspicious cells during EBUS-TBNA. If only the patients for whom pathologic tissue confirmation was available are considered (EBUS-TBNA or mediastinoscopy), 25 of 42 (60%) had specimens acquired by EBUS-TBNA that established a definitive diagnosis of a specific LPD, whereas the remainder required mediastinoscopy. In contrast, if we also include the 23 patients who met the radiographic criteria for mediastinal or hilar involvement, or both, only 25 of 65 patients (38%) had EBUS-TBNA specimens sufficient for definitive diagnosis. Upon independent review of the slides, discordance occurred between initial and blinded review in 6 patients for whom the reviewing pathologist determined that the EBUS-TBNA specimens were insufficient for diagnosis of a LPD. Four of these patients had a history of a LPD, were assumed to have recurrence of their prior subtype, and were treated accordingly. One of the remaining 2 patients was diagnosed on the basis of molecular genetic evidence of a clonal immunoglobulin gene rearrangement, without histologic or phenotypic findings of lymphoma. This patient underwent subsequent mediastinoscopy for de-
4 Ann Thorac Surg IQBAL ET AL 2012;94: EBUS-TBNA FOR LYMPHOPROLIFERATIVE DISEASES finitive diagnosis and treatment. The other patient underwent a concurrent endobronchial mucosa biopsy during the EBUS-TBNA, and the specimen demonstrated B-cell lymphoma that likely influenced the initial EBUS- TBNA pathologic results. Therefore, our expert blinded review suggests that in the absence of any clinical history or radiographic data, the overall sensitivity of EBUS- TBNA for accurately diagnosing a LPD is 19 of 65 (29%). Comment Contrary to previous studies suggesting that EBUS- TBNA may be an appropriate initial investigation for the diagnosis of isolated mediastinal or hilar lymphadenopathy suspicious for a LPD, our study demonstrates that EBUS-TBNA does not provide adequate pathologic tissue samples for accurate characterization and subtyping of LPDs in a significant number of cases. Sensitivity of EBUS-TBNA for the definitive diagnosis of a LPD was at best 60% when only cases with pathologic confirmation were taken into account; however, a more conservative analysis, including cases in which involvement of the mediastinum or hila was assumed based on established radiographic criteria, resulted in a sensitivity of only 29%. Furthermore, 62% of patients were exposed to the attendant risks of a subsequent invasive procedure (eg, mediastinoscopy, excisional lymph node biopsy, endoscopy) to establish a definitive diagnosis and guide therapy. In the patients for whom EBUS-TBNA was able to establish a definitive diagnosis of a LPD, 72% were presumed to have a recurrence of a prior established LPD, suggesting that EBUS-TBNA may have limited utility in establishing new diagnoses of LPDs but may have a role in evaluating patients for possible recurrence of a prior LPD. Four of the 6 instances in which a discrepancy was found in the independent blinded pathology review were recurrences, suggesting that clinical history and radiographic data likely influenced the interpretation of the EBUS-TBNA specimen. All of these specimens were noted to have inadequate material, with minimal cellularity accompanied by increased tissue distortion upon independent review. Establishing a new 1833 diagnosis of a LPD is highly dependent on sufficient pathologic tissue samples, which our data would suggest is not routinely attainable by EBUS-TBNA. However, EBUS-TBNA may be a reasonable initial diagnostic tool in patients with a history of a prior LPD when the detection of malignant cells is usually sufficient to establish recurrence and guide therapy. Three previous smaller studies have suggested a higher overall sensitivity from 57% to 91% for EBUS- TBNA in the diagnosis of LPDs [12 14]. However, the analysis published by Kennedy and colleagues [12] reporting a sensitivity of 91% in 11 patients did not account for the fact that 2 of these patients required mediastinoscopy for subtyping of their LPD. A more conservative analysis of their data would suggest a sensitivity of 8 of 11 (73%) for definitive diagnosis of a LPD by EBUS-TBNA. In addition, 8 of their 11 patients had a history of a LPD. This was similar in the study by Marshall and colleagues [13], in which 6 of the 8 patients definitively diagnosed with a LPD by EBUS-TBNA were recurrent cases. In another study, by Steinfort and colleagues [14], only 2 of the 21 patients diagnosed with a LPD by EBUS-TBNA were recurrent; however, the reported overall sensitivity in their study was lower, at 57%. Our overall sensitivity of 38% for all patients is lower than in these reports. However, our sensitivity for diagnosing recurrent cases of LPDs using EBUS-TBNA alone was 18 of 33 (55%), which compares favorably with the prior reports predominately composed of patients with recurrence. However, our sensitivity for diagnosing new LPDs was only 7 of 32 (22%), suggesting that EBUS-TBNA is not the procedure of choice for initial evaluation of patients in whom there is significant clinical suspicion for a LPD involving the mediastinum or hilum (Fig 2). This is further supported by a recent study published by Navani and colleagues [20] reporting a sensitivity of only 33% for the definitive diagnosis of lymphoma involving the mediastinum, although the low number of patients with lymphoma in that study arguably precludes definitive conclusions [21]. We acknowledge several limitations to our study. First, this retrospective analysis limited the study to patients Fig 2. Diagram illustrates the method by which diagnosis was made for new vs recurrent cases. (Dx diagnosis; EBUS-TBNA endobronchial ultrasound-guided transbronchial needle aspiration; LPD lymphoproliferative disease; Med mediastinoscopy.)
5 1834 IQBAL ET AL Ann Thorac Surg EBUS-TBNA FOR LYMPHOPROLIFERATIVE DISEASES 2012;94: who were ultimately diagnosed with LPD on the basis of EBUS-TBNA, mediastinoscopy, or specimens from other biopsies. We could not retrospectively identify all mediastinal or hilar lymphadenopathy suspicious for a LPD, limiting our analysis to sensitivity (and not specificity). However, our primary goal was to determine how often a definitive diagnosis of a LPD precise enough to allow for determination of specific management could be established by EBUS-TBNA. Another limitation is the small sample size of our study. However, even when considering only those patients with mediastinal or hilar tissue confirmation, our study remains the largest series reported. Finally, we did not use flow cytometry routinely when evaluating EBUS-TBNA specimens. The entire tissue specimens were used for histologic assessment and immunohistochemistry. The experience of our hematopathology group has been that this approach optimizes the opportunity for establishing accurate subtyping of LPDs based on morphology and immunoarchitecture in small specimens, a necessity for appropriate therapeutic decision making. In summary, our results suggest that EBUS-TBNA may not provide adequate pathologic specimens in most of the patients with mediastinal or hilar lymphadenopathy in whom a new diagnosis of a LPD is suspected. In our opinion, other alternatives should be considered. Mediastinoscopy, which provides significantly larger pathology specimens, should continue to be considered as the initial diagnostic procedure of choice in these patients. Alternatively, EBUS-TBNA could be considered a suitable alternative when recurrence of a prior LPD is suspected or when the clinical suspicion of a LPD is low. This work received funding from Mayo Clinic Foundation, the Division of Hematology, and the Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota. References 1. Yasufuku K, Chiyo M, Sekine Y, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest 2004;126: Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006;61: Herth FJ, Ernst A, Eberhardt R, Vilmann P, Dienemann H, Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur Respir J 2006;28: Vincent BD, El-Bayoumi E, Hoffman B, et al. Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg 2008;85: Kennedy MP, Jimenez CA, Morice RC, et al. Factors influencing the diagnostic yield of endobronchial ultrasoundguided transbronchial needle aspiration. J Bronchol 2010;17: Adams K, Shah PL, Edmonds L, Lim E. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: Systematic review and meta-analysis. Thorax 2009; 64: Harewood GC, Pascual J, Raimondo M, et al. Economic analysis of combined endoscopic and endobronchial ultrasound in the evaluation of patients with suspected nonsmall cell lung cancer. Lung Cancer 2010;67: Steinfort DP, Liew D, Conron M, Hutchinson AF, Irving LB. Cost-benefit of minimally invasive staging of non-small cell lung cancer: a decision tree sensitivity analysis. J Thorac Oncol 2010;5: Garwood S, Judson MA, Silvestri G, Hoda R, Fraig M, Doelken P. Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest 2007;132: Wong M, Yasufuku K, Nakajima T, et al. Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J 2007;29: Tremblay A, Stather DR, Maceachern P, Khalil M, Field SK. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest 2009;136: Kennedy M, Jimenez C, Bruzzi J, et al. Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lymphoma. Thorax 2008;63: Marshall C, Jacob B, Patel S, et al. The utility of endobronchial ultrasound-guided transbronchial needle aspiration biopsy in the diagnosis of mediastinal lymphoproliferative disorders. Cancer Cytopathol 2011;119: Steinfort D, Conron M, Tsui A, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for the evaluation of suspected lymphoma. J Thorac Oncol 2010;5: Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours and haematopoietic and lymphoid tissues. Lyon, France: IARC Press; Mountain C, Dresler C. Regional lymph node classification for lung cancer staging. Chest 1997;111: Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4: Meignan M, Gallamini A, Haioun C. Report on the first international workshop on interim-pet-scan in lymphoma. Leuk Lymphoma 2009;50: Lee HS, Lee GK, Kim MS, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest 2008;134: Navani N, Lawrence D, Kolvekar S, et al. Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy. Am J Respir Crit Care Med 2012; 186: Currie G, Miller D. Endobronchial ultrasound in mediastinal lymphadenopathy: cutting costs not patients? Am J Respir Crit Care Med 2012;186:208 9.
Diagnostic Value of EBUS-TBNA in Various Lung Diseases (Lymphoma, Tuberculosis, Sarcoidosis)
Diagnostic Value of EBUS-TBNA in Various Lung Diseases (Lymphoma, Tuberculosis, Sarcoidosis) Sevda Sener Cömert, MD, FCCP. SBU, Kartal Dr.Lütfi Kırdar Training and Research Hospital Department of Pulmonary
More informationEndobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer
Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP Lead Lung Cancer Clinician, Consultant Respiratory Physician & Speciality Director Manchester University NHS
More informationThe Various Methods to Biopsy the Lung PROF SHITRIT DAVID HEAD, PULMONARY DEPARTMENT MEIR MEDICAL CENTER, ISRAEL
The Various Methods to Biopsy the Lung PROF SHITRIT DAVID HEAD, PULMONARY DEPARTMENT MEIR MEDICAL CENTER, ISRAEL Conflict of Interest This presentation is supported by AstraZeneca Two main steps before
More informationEBUS-TBNA in PET-positive lymphadenopathies in treated cancer patients
ORIGINAL ARTICLE LUNG IMAGING EBUS-TBNA in PET-positive lymphadenopathies in treated cancer patients Juliana Guarize 1, Monica Casiraghi 1, Stefano Donghi 1, Chiara Casadio 2, Cristina Diotti 1, Niccolò
More informationAccurate mediastinal staging is a critical component
Endobronchial Ultrasound for Lung Cancer Staging: How Many Stations Should Be Sampled? Mark I. Block, MD Thoracic Surgery, Memorial Healthcare System, Hollywood, Florida Background. No guidelines exist
More informationINTRODUCTION. Jpn J Clin Oncol 2013;43(11) doi: /jjco/hyt123 Advance Access Publication 29 August 2013
Jpn J Clin Oncol 2013;43(11)1110 1114 doi:10.1093/jjco/hyt123 Advance Access Publication 29 August 2013 Usefulness of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in Distinguishing
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal
More informationMediastinal Incidentalomas
ORIGINAL ARTICLE Jos A. Stigt, MD,* James E. Boers, MD, PhD, Ad H. Oostdijk, MD, Jan-Willem K. van den Berg, MD, PhD,* and Harry J. M. Groen, MD, PhD Introduction: Incidental mediastinal lymphadenopathy
More informationStandardized transbronchial needle aspiration procedure for intrathoracic lymph node staging of non-small cell lung cancer
Original Article on Transbronchial Needle Aspiration (TBNA) Standardized transbronchial needle aspiration procedure for intrathoracic lymph node staging of non-small cell lung cancer Xu-Ru Jin 1 *, Min
More informationA Standard Endobronchial Ultrasound Image Classification System
CHEST Original Research INTERVENTIONAL PULMONOLOGY The Utility of Sonographic Features During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Lung
More informationMediastinal Staging. Samer Kanaan, M.D.
Mediastinal Staging Samer Kanaan, M.D. Overview Importance of accurate nodal staging Accuracy of radiographic staging Mediastinoscopy EUS EBUS Staging TNM Definitions T Stage Size of the Primary Tumor
More informationEndobronchial ultrasound-guided transbronchial needle aspiration
ORIGINAL ARTICLE Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Evaluation of Suspected Lymphoma Daniel P. Steinfort, MBBS, FRACP,* Matthew Conron, MBBS, FRACP, Alpha Tsui, MBBS,
More informationEndobronchial ultrasound-guided lymph node biopsy with transbronchial needle forceps: a pilot study
Eur Respir J 2012; 39: 373 377 DOI: 10.1183/09031936.00033311 CopyrightßERS 2012 Endobronchial ultrasound-guided lymph node biopsy with transbronchial needle forceps: a pilot study F.J.F. Herth*, H. Schuler*,
More informationBronchoscopy and endobronchial ultrasound for diagnosis and staging of lung cancer
FRANCISCO AÉCIO ALMEIDA, MD, MS, FCCP Associate Staff Member, Director, Interventional Pulmonary Medicine Fellowship Program, Respiratory Institute, Cleveland Clinic, Cleveland, OH Bronchoscopy and endobronchial
More informationUtilizing EBUS (Endobronchial Ultrasound) for Diagnosis of Lung Cancer and other Pulmonary Diseases
Utilizing EBUS (Endobronchial Ultrasound) for Diagnosis of Lung Cancer and other Pulmonary Diseases Akintayo Sokunbi, M.D MidMichigan Hospital Midland, Michigan Objectives Discuss EBUS guided biopsy principles
More informationSubhash Chandra MD, Mahendra Nehra MD, Dipti Agarwal MD, and Anant Mohan MD
Diagnostic Accuracy of Endobronchial Ultrasound-Guided Transbronchial Needle Biopsy in Mediastinal Lymphadenopathy: A Systematic Review and Meta-analysis Subhash Chandra MD, Mahendra Nehra MD, Dipti Agarwal
More informationThe diagnostic efficacy and safety of endobronchial ultrasound-guided transbronchial needle aspiration as an initial diagnostic tool
ORIGINAL ARTICLE Korean J Intern Med 2013;28.660-667 The diagnostic efficacy and safety of endobronchial ultrasound-guided transbronchial needle aspiration as an initial diagnostic tool Young Rak Choi
More informationEndobronchial Ultrasound Guided Transbronchial Needle Aspiration in the Diagnosis of Lymphoma.
Thorax Online First, published on October 26, 200 as 10.1136/thx.200.08409 Title Page Endobronchial Ultrasound Guided Transbronchial Needle Aspiration in the Diagnosis of. Marcus P Kennedy MD 1, Carlos
More informationClinical Management Guideline for Small Cell Lung Cancer
Diagnosis and Staging: Key Points 1. Ensure a CT scan that is
More informationSubject: Virtual Bronchoscopy and Electromagnetic Navigational Bronchoscopy for Evaluation of Peripheral Pulmonary Lesions
Subject: Virtual Bronchoscopy and Electromagnetic Navigational Bronchoscopy for Evaluation of Peripheral Pulmonary Lesions Original Effective Date: 8/25/14 Policy Number: MCP-206 Revision Date(s): Review
More informationLooking beyond the bronchial wall.
10th anniversary of scientific study ON EBUS-TBNA A review Looking beyond the bronchial wall. Am J Respir Crit Care Med Eur Respir J Endoscopy Chest JAMA Thorax J Bronchol J Clin Oncol J Thorac Oncol Ann
More informationThe Itracacies of Staging Patients with Suspected Lung Cancer
The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung
More informationIntroduction to Interventional Pulmonology
Introduction to Interventional Pulmonology Alexander Chen, M.D. Director, Interventional Pulmonology Assistant Professor of Medicine and Surgery Divisions of Pulmonary and Critical Care Medicine and Cardiothoracic
More informationAbhishek Biswas 1, John P. Wynne 2, Divya Patel 1, Michelle Weber 3, Shaleen Thakur 4, P. S. Sriram 1
Letter to the Editor Comparison of the yield of 19-G excelon core needle to a 21-G EUS needle during endobronchial ultrasound guided transbronchial needle aspiration of mediastinal lymph nodes for the
More informationEndobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lymphoma
1 Department of Pulmonary Medicine, University of Texas MD 2 Department of Radiology, 3 Department of Statistics, 4 Department of Leukemia, 5 Department of Pathology, Houston, Texas, USA Correspondence
More informationAccurate staging of non-small cell lung cancer (NSCLC) is
ORIGINAL ARTICLE Cost-Benefit of Minimally Invasive Staging of Non-small Cell Lung Cancer A Decision Tree Sensitivity Analysis Daniel P. Steinfort, MBBS, FRACP,* Danny Liew, MBBS, FRACP, PhD, Matthew Conron,
More informationORIGINAL ARTICLE Oncology & Hematology INTRODUCTION MATERIALS AND METHODS
ORIGINAL ARTICLE Oncology & Hematology http://dx.doi.org/10.3346/jkms.2013.28.4.550 J Korean Med Sci 2013; 28: 550-554 Clinical Implication of Microscopic Anthracotic Pigment in Mediastinal Staging of
More informationMEDIASTINAL STAGING surgical pro
MEDIASTINAL STAGING surgical pro Paul E. Van Schil, MD, PhD Department of Thoracic and Vascular Surgery University of Antwerp, Belgium Mediastinal staging Invasive techniques lymph node mapping cervical
More informationMediastinal lymphadenopathy is a common finding in
ORIGINAL ARTICLE Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Intrathoracic Lymphadenopathy in Patients with Extrathoracic Malignancy A Multicenter Study Neal Navani,
More informationUse of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS- TBNA) in the Diagnosis of Granulomatous Mediastinal Lymphadenopathy
Original Article 250 Use of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS- TBNA) in the Diagnosis of Granulomatous Mediastinal Lymphadenopathy Su Ying Low, 1 BMBCh, Mariko S Koh,
More informationGeneral Thoracic Surgery
General Thoracic Surgery Oki et al Prospective study of endobronchial ultrasound guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue for diagnosis of
More informationFelix J. F. Herth, MD, FCCP; Ralf Eberhardt, MD; Mark Krasnik, MD; and Armin Ernst, MD, FCCP
Original Research INTERVENTIONAL PULMONOLOGY Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Lymph Nodes in the Radiologically and Positron Emission Tomography-Normal Mediastinum in
More informationMulticentric study of endobronchial ultrasound-transbronchial needle aspiration for lung cancer staging in Italy
Original Article Multicentric study of endobronchial ultrasound-transbronchial needle aspiration for lung cancer staging in Italy Nicola Rotolo 1, Andrea Imperatori 1, Mario Nosotti 2, Luigi Santambrogio
More informationEndobronchial Ultrasound for Diagnosis and Staging of Lung Cancer
Endobronchial Ultrasound for Diagnosis and Staging of Lung Cancer Policy Number: 6.01.58 Last Review: 08/2017 Origination: 08/2015 Next Review: 08/2018 Policy Blue Cross and Blue Shield of Kansas City
More informationEndobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Diagnosis of Lymphoma
RESEARCH ARTICLE Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Diagnosis of Lymphoma Aysegul Senturk 1 *, Elif Babaoglu 1, Hatice Kilic 1, Habibe Hezer 1, Hayriye Tatli Dogan
More informationElectromagnetic Navigation Bronchoscopy
Medical Policy Manual Surgery, Policy No. 179 Electromagnetic Navigation Bronchoscopy Next Review: March 2018 Last Review: March 2017 Effective: May 1, 2017 IMPORTANT REMINDER Medical Policies are developed
More informationUtility of PET-CT for detection of N2 or N3 nodal mestastases in the mediastinum in patients with non-small cell lung cancer (NSCLC)
Utility of PET-CT for detection of N2 or N3 nodal mestastases in the mediastinum in patients with non-small cell lung cancer (NSCLC) Poster No.: C-1360 Congress: ECR 2015 Type: Scientific Exhibit Authors:
More informationFNA, ROSE and ancillary tests. Principles and Practice. Dr Tony Maddox Consultant cyto/histopathologist
FNA, ROSE and ancillary tests Principles and Practice Dr Tony Maddox Consultant cyto/histopathologist ROSE what does it mean? Rapid OnSite Evaluation, but To what end? Using what methods? Performed by
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationEndoscopic ultrasound-guided needle aspiration in lung cancer
ORIGINAL ARTICLE Artur Szlubowski 1, Marcin Zieliński 1, Joanna Figura 1, Jolanta Hauer 1, Witold Sośnicki 1, Juliusz Pankowski 2, Anna Obrochta 2, Magdalena Jakubiak 2 1 Department of Thoracic Surgery
More informationRole of EBUS in mediastinal staging of lung cancer. -Dr. Nandakishore Baikunje
Role of EBUS in mediastinal staging of lung cancer -Dr. Nandakishore Baikunje Overview of the seminar Introduction Endosonography to stage the mediastinum Technical aspects of EBUS-TBNA for mediastinal
More informationResearch Article The Use of Endobronchial Ultrasound in the Diagnosis of Subacute Pulmonary Histoplasmosis
Diagnostic and erapeutic Endoscopy Volume 2015, Article ID 510863, 6 pages http://dx.doi.org/10.1155/2015/510863 Research Article The Use of Endobronchial Ultrasound in the Diagnosis of Subacute Pulmonary
More informationPrimary lung cancer is the most frequent cause of death
Original Article Endobronchial Ultrasound versus Mediastinoscopy for Mediastinal Nodal Staging of Non Small-Cell Lung Cancer Sang-Won Um, MD, PhD,* Hong Kwan Kim, MD, PhD, Sin-Ho Jung, PhD, Joungho Han,
More informationSpecimen Processing Techniques for Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
Specimen Processing Techniques for Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Jennifer W. Toth, MD, Konstantin Zubelevitskiy, MD, Jennifer A. Strow, DO, Jussuf T. Kaifi, MD, PhD,
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationCorporate Medical Policy Electromagnetic Navigation Bronchoscopy
Corporate Medical Policy Electromagnetic Navigation Bronchoscopy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: electromagnetic_navigation_bronchoscopy 1/2010 3/2017 3/2018 9/2017
More informationORIGINAL RESEARCH. Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for the Diagnosis and Subtyping of Lymphoma.
Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for the Diagnosis and Subtyping of Horiana B. Grosu 1, Mihai Iliesiu 2, Nancy P. Caraway 3, L. Jeffrey Medeiros 4, Xiudong Lei 5, Carlos
More informationAn Update: Lung Cancer
An Update: Lung Cancer Andy Barlow Consultant in Respiratory Medicine Lead Clinician for Lung Cancer (West Herts Hospitals NHS Trust) Lead for EBUS-Harefield Hospital (RB&HFT) Summary Lung cancer epidemiology
More informationGENERAL THORACIC SURGERY
GENERAL THORACIC SURGERY A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer
More informationEndobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer
Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP ESMO-Christie Lung Cancer Course Manchester 2017 Overview What is Endobronchial Ultrasound? Why & When Do We
More informationEndobronchial ultrasound: what is it and when should it be used?
CLINICAL PRACTICE Clinical Medicine 2010, Vol 10, No 5: 458 63 Endobronchial ultrasound: what is it and when should it be used? ARL Medford ABSTRACT Endobronchial ultrasound has become increasingly used
More informationSection: Radiology Effective Date: July 15, 2016 Subsection: Original Policy Date: March 20, 2015 Subject:
Last Review Status/Date: June 2016 Page: 1 of 14 Endobronchial Ultrasound for Diagnosis and Summary Endobronchial ultrasound (EBUS) is a technique that enhances standard flexible bronchoscopy by providing
More informationAssessing the lung and mediastinum in cancer-is tissue the issue? George Santis
1 Assessing the lung and mediastinum in cancer-is tissue the issue? George Santis Optimal management of Cancer Histological diagnosis & accurate staging at presentation Molecular analysis of primary tumour
More informationEndobronchial ultrasound-guided transbronchial needle aspiration for staging of non-small cell lung cancer
Surgical Technique on Thoracic Surgery Page 1 of 6 Endobronchial ultrasound-guided transbronchial needle aspiration for staging of non-small cell lung cancer Habiba Hashimi 1, David T. Cooke 1, Elizabeth
More informationEndobronchial Ultrasound in the Diagnostic Evaluation of Sarcoidosis
Chapter 10 Endobronchial Ultrasound in the Diagnostic Evaluation of Sarcoidosis Abiramy Jeyabalan and Andrew RL Medford Additional information is available at the end of the chapter http://dx.doi.org/10.5772/55167
More informationEndobronchial Ultrasound-guided Transbronchial Needle Aspiration in a Patient with Pericardial Mesothelioma
CASE REPORT Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in a Patient with Pericardial Mesothelioma Hironori Ashinuma 1, Masato Shingyoji 1, Yasushi Yoshida 1, Meiji Itakura 1, Fumihiro
More informationMediastinal Mysteries: What can be solved with EBUS?
Mediastinal Mysteries: What can be solved with EBUS? W. Graham Carlos MD Pulmonary & Critical Care Fellow Indiana University School of Medicine Disclosures None Objectives Introduce you to the technique
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationThe Role of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in the Diagnosis of Recurrent Non-small Cell Lung Cancer after Surgery
ORIGINAL ARTICLE The Role of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in the Diagnosis of Recurrent Non-small Cell Lung Cancer after Surgery Seo Goo Han 1, Hongseok Yoo 1, Byung
More informationENDOBRONCHIAL ULTRASOUND (EBUS) TRAINING PROGRAMME CURRICULUM
ENDOBRONCHIAL ULTRASOUND (EBUS) TRAINING PROGRAMME CURRICULUM This competency-based curriculum has been designed by a task force of interventional pulmonology specialists to underline the learning outcomes
More informationLung Cancer staging Role of ENDOBRONCHIAL ULTRASOUND(Ebus) EBUS
Lung Cancer staging Role of ENDOBRONCHIAL ULTRASOUND(Ebus) Arvind Perathur Winter Retreat Feb 13 th 2011 Mason City IA 50401 EBUS Tiger now offers a very economical and environmentally friendly all electric
More informationOwing to the recent attention given to lung cancer
Electromagnetic : A Surgeon s Perspective Todd S. Weiser, MD, Kevin Hyman, MD, Jaime Yun, MD, Virginia Litle, MD, Cythinia Chin, MD, and Scott J. Swanson, MD Department of Cardiothoracic Surgery, Mount
More informationGROUP 1: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases. Including: Excluding:
GROUP 1: Including: Excluding: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases Solid pulmonary nodules 8mm diameter / 300mm3 volume and BROCK risk of malignancy
More informationMinimally Invasive Mediastinal Staging of Non Small-Cell Lung Cancer: Emphasis on Ultrasonography-Guided Fine-Needle Aspiration
Endobronchial ultrasound and endoscopic ultrasound-guided lymph node biopsy may represent an alternative to cervical mediastinoscopy. Dorothy Fox, Rough Seas. Acrylic on canvas, 36ʺ 36ʺ. Minimally Invasive
More informationElectromagnetic navigational bronchoscopy in patients with solitary pulmonary nodules
Original article Electromagnetic navigational bronchoscopy in patients with solitary pulmonary nodules Samuel Copeland MD, Shrinivas Kambali MD, Gilbert Berdine MD, Raed Alalawi MD Abstract Background:
More informationExercise 15: CSv2 Data Item Coding Instructions ANSWERS
Exercise 15: CSv2 Data Item Coding Instructions ANSWERS CS Tumor Size Tumor size is the diameter of the tumor, not the depth or thickness of the tumor. Chest x-ray shows 3.5 cm mass; the pathology report
More informationEndoscopic and Endobronchial Ultrasound Staging for Lung Cancer. Michael B. Wallace, MD, MPH Professor of Medicine Mayo Clinic, Jacksonville
Endoscopic and Endobronchial Ultrasound Staging for Lung Cancer Michael B. Wallace, MD, MPH Professor of Medicine Mayo Clinic, Jacksonville Background: Lung Cancer 170,000 cases/yr in U.S. (# 1 cancer)
More informationPredicting malignancy in mediastinal lymph nodes by endobronchial ultrasound: A new ultrasound scoring system
bs_bs_banner ORIGINAL ARTICLE Predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound: A new ultrasound scoring system GERALD SCHMID-BINDERT, 1 HONGBIN JIANG, 5 GEORG KÄHLER, 1 JOACHIM
More informationIn 1982 Pearson and colleagues [1] from Toronto published
Transition From Mediastinoscopy to Endoscopic Ultrasound for Lung Cancer Staging Mark I. Block, MD Division of Thoracic Surgery, Memorial Healthcare System, Hollywood, Florida Background. Esophageal endoscopic
More informationLarry Tan, MD Thoracic Surgery, HSC. Community Cancer Care Educational Conference October 27, 2017
Larry Tan, MD Thoracic Surgery, HSC Community Cancer Care Educational Conference October 27, 2017 To describe patient referral & triage for the patient with suspected lung cancer To describe the initial
More informationPatient Satisfaction During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Performed Under Conscious Sedation
Patient Satisfaction During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Performed Under Conscious Sedation Daniel P Steinfort MBBS FRACP and Louis B Irving MBBS FRACP BACKGROUND: Mediastinal
More informationUtility of endobronchial ultrasound guided mediastinal lymph node biopsy in patients with non small cell lung cancer
GENERAL THORACIC SURGERY Utility of endobronchial ultrasound guided mediastinal lymph node biopsy in patients with non small cell lung cancer Benjamin E. Lee, MD, a,b Elaine Kletsman, PA, a,b John R. Rutledge,
More informationK Adams, 1 P L Shah, 2 L Edmonds, 3 E Lim 1. Lung cancer
c Appendices A and B are published online only at http:// thorax.bmj.com/content/vol64/ issue9 1 Imperial College and Academic Division of Thoracic Surgery, Royal Brompton Hospital, London, UK; 2 Department
More informationChest radiograph of an. asymptomatic man. Case report. Case history
Eleftheria Chaini 1, Niki Giannakou 2, Dimitra Haini 3, Anna Maria Athanassiadou 4, Angelos Tsipis 4, Nikolaos D. Hainis 5 elhaini@otenet.gr 1 Pulmonary Dept, Corfu General Hospital, Kontokali, Greece.
More informationApproach to Pulmonary Nodules
Approach to Pulmonary Nodules Edwin Jackson, Jr., DO Assistant Professor-Clinical Director, James Early Detection Clinic Department of Internal Medicine Division of Pulmonary, Allergy, Critical Care and
More informationGTS. The Journal of Thoracic and Cardiovascular Surgery Volume 134, Number
Nakajima et al The evaluation of lymph node metastasis by endobronchial ultrasound-guided transbronchial needle aspiration: Crucial for selection of surgical candidates with metastatic lung tumors Takahiro
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationPredictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer
Original Article Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer Feichao Bao, Ping Yuan, Xiaoshuai Yuan, Xiayi Lv, Zhitian Wang, Jian Hu Department
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationLugano classification: Role of PET-CT in lymphoma follow-up
CAR Educational Exhibit: ID 084 Lugano classification: Role of PET-CT in lymphoma follow-up Charles Nhan 4 Kevin Lian MD Charlotte J. Yong-Hing MD FRCPC Pete Tonseth 3 MD FRCPC Department of Diagnostic
More informationCytology Workshop #3
Cytology Workshop #3 Jennifer Brainard, MD Christine Booth, MD Disclosure information The speaker has no relationship that represents a possible conflict of interest with respect to the content of this
More informationPathologic staging of the mediastinal lymph nodes is
Mediastinoscopy: Still the Gold Standard Joseph B. Shrager, MD Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, and Veterans Administration
More informationPre-operative Ultrasound of Lymph Nodes in Thyroid Cancer
Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer AACE - Advances in Medical and Surgical Management of Thyroid Cancer - 2018 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel
More informationUNDERSTANDING SERIES LUNG CANCER BIOPSIES LungCancerAlliance.org
UNDERSTANDING SERIES LUNG CANCER BIOPSIES 1-800-298-2436 LungCancerAlliance.org CONTENTS What is a Biopsy?...2 Non-Surgical Biopsies...3 Surgical Biopsies...5 Biopsy Risks...6 Biopsy Results...6 Questions
More informationISSN: (Print)/ (Online) Tuberc Respir Dis 2014;77:
CASE REPORT http://dx.doi.org/10.4046/trd.2014.77.4.188 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2014;77:188-192 New-Onset Malignant Pleural Effusion after Abscess Formation of a Subcarinal
More informationClinical evaluation of the utility of a flexible 19-gauge EBUS-TBNA needle
Original Article Clinical evaluation of the utility of a flexible 19-gauge EBUS-TBNA needle Tomonari Kinoshita 1,2, Hideki Ujiie 1, Joerg Schwock 3, Kosuke Fujino 1, Christine McDonald 1, Chang Young Lee
More informationEndobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a concise review
Review Article Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a concise review Fahad Aziz Department of Internal Medicine, Section on Hospital Medicine, Wake
More informationTake Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules
Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in
More informationMEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT POLICY GUIDELINES DESCRIPTION. Page: 1 of 6
Page: 1 of 6 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY Policy Number 6.01.40 Category Technology Assessment Effective Date 04/21/11 Revised Date
More informationLes techniques invasives et minimalement invasives dans le staging du cancer bronchopulmonaire. V. Ninane, Hôpital Saint-Pierre, Bruxelles, Belgique
Les techniques invasives et minimalement invasives dans le staging du cancer bronchopulmonaire V. Ninane, Hôpital Saint-Pierre, Bruxelles, Belgique 1 Invasive Mediastinal Staging Purpose : to exclude Involvement
More informationPET CT for Staging Lung Cancer
PET CT for Staging Lung Cancer Rohit Kochhar Consultant Radiologist Disclosures Neither I nor my immediate family members have financial relationships with commercial organizations that may have a direct
More informationJessa Hospital - Hasselt, Belgium
- Hasselt, Belgium General Information New breast cancer cases treated per year 336 Breast multidisciplinarity team members 19 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationA study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA
To cite: Evison M, Crosbie PAJ, Morris J, et al. A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA. BMJ Open Resp Res 2014;1:e000040. doi:10.1136/bmjresp-2014-000040
More informationElectromagnetic Navigation Bronchoscopy
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationElectromagnetic Navigation Bronchoscopy
Electromagnetic Navigation Bronchoscopy Policy Number: 7.01.122 Last Review: 9/2017 Origination: 1/2010 Next Review: 9/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide coverage
More informationElectromagnetic Navigation Bronchoscopy
Electromagnetic Navigation Bronchoscopy Policy Number: 7.01.122 Last Review: 9/2018 Origination: 1/2010 Next Review: 9/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide coverage
More informationAldo Carnevale 1, Gianluca Milanese 2,3, Nicola Sverzellati 2, Mario Silva 2,3
Editorial Page 1 of 7 novel prediction model for the probability of mediastinal lymph node metastases detected by endobronchial ultrasound-transbronchial needle aspiration in non-small cell lung cancer:
More informationEndoscopic Ultrasound-Guided Fine- Needle Aspiration for Non-small Cell Lung Cancer Staging* A Systematic Review and Metaanalysis
CHEST Endoscopic Ultrasound-Guided Fine- Needle Aspiration for Non-small Cell Lung Cancer Staging* A Systematic Review and Metaanalysis Carlos G. Micames, MD; Douglas C. McCrory, MD; Darren A. Pavey, MD;
More informationREVIEW ARTICLES. Aslam Khan, Shahid Jamal, Jawad Khaliq Ansari, Arshad Naseem
REVIEW ARTICLES A REVIEW OF ENDOBRONCHIAL ULTRASOUND GUIDED TRANSBRONCHIAL NEEDLE ASPIRATE (EBUS-TBNA) Aslam Khan, Shahid Jamal, Jawad Khaliq Ansari, Arshad Naseem Army Medical College & National University
More information